MMJ PhytoTech Limited (ASX:MMJ) is pleased to announce that through its subsidiary UG, it has received full occupancy at the state-of-the-art Duncan Facility located near Vancouver, British Columbia, Canada. UG was issued an Occupancy Permit as expected on 2 November 2015 after provincial and municipal review and approval. Being the last remaining approval needed, MMJ has officially notified Health Canada that Duncan is ready for Pre-Licensing Inspection and has requested a date for inspection as soon as possible.Highlights
- MMJ PhytoTech's ("MMJ" or the "Company") wholly owned subsidiary United Greeneries ("UG") received full occupancy of Duncan Facility ("Duncan") on 2 November 2015
- Comprehensive response to Health Canada's ("HC") 1 April 2015 "Confirmation of Readiness" letter submitted by MMJ on 3 November 2015; Immediate date for Pre-Licensing Inspection has been requested
- PreLicensing Inspection final step to receiving a cultivation license from HC under the Marijuana for Medical Purposes Regulations ("MMPR")
- After completion of finishing, enhancement and optimization project, Duncan is a state-of-the-art potential MMPR facility
- Management is confident that all potential deficiencies identified by Health Canada and by the Company have been adequately addressed
- Additionally, several voluntary optimization improvements have been completed which are expected to dramatically improve work flow and capacity of Duncan
- Duncan to produce up to 1,000 kg of Medical Cannabis ("MC") per year at full capacity
Duncan Undergoes Big Changes since April 1 2015
- Letter to Health Canada was technically a response to the April 1 2015 "Confirmation of Readiness" letter
- April 1st letter directly and indirectly identified a small number of potential deficiencies which have now been rectified
- Further, several non-mandatory optimisations, aesthetic improvements and finishings have been completed with the aim of improving work flow and capacity
- Duncan is now a state-of-the-art potential MMPR facility capable of producing up to1,000 kg/year of MC
- Key structural modifications and installations:
* Dropping the ceiling in the vault;
* State-of-the-art surveillance system;
* New HVAC system;
* New Irrigation system; and
* Various enhancements to grow room.
Strategic Importance of MMPR License
- The Duncan MMPR license will provide MMJ with a secure and legal source of MC for processing into higher value compounds and potentially pharmaceuticals in line with MMJ's "Farm to Pharma" strategy
- MMPR license at Duncan could potentially expedite the rollout of domestic extraction infrastructure in Satipharm Canada
- In the interim the license could facilitate the importation and sale of CBD capsules from Europe which would give MMJ a significant first mover advantage in the newly formed and currently unserved extracts market
- The leading character and federal positioning of the Canadian MMPR will allow for knowledge and expertise transfer into new and emerging MC markets, including Australia
Andreas Gedeon Managing Director T: +1 (250) 713 6302 E: agedeon@mmj.ca For media enquiries Media & Capital Partners Asher Moses, Director T: +61 438 008 616 MMJ PhytoTech Ltd T: +61 8 9389 3150 E: info@mmjphytotech.com.au WWW: www.mmjphytotech.com.au
